<code id='3B7403D547'></code><style id='3B7403D547'></style>
    • <acronym id='3B7403D547'></acronym>
      <center id='3B7403D547'><center id='3B7403D547'><tfoot id='3B7403D547'></tfoot></center><abbr id='3B7403D547'><dir id='3B7403D547'><tfoot id='3B7403D547'></tfoot><noframes id='3B7403D547'>

    • <optgroup id='3B7403D547'><strike id='3B7403D547'><sup id='3B7403D547'></sup></strike><code id='3B7403D547'></code></optgroup>
        1. <b id='3B7403D547'><label id='3B7403D547'><select id='3B7403D547'><dt id='3B7403D547'><span id='3B7403D547'></span></dt></select></label></b><u id='3B7403D547'></u>
          <i id='3B7403D547'><strike id='3B7403D547'><tt id='3B7403D547'><pre id='3B7403D547'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:85
          Senate health committee Chair Bernie Sanders
          Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

          Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

          advertisement

          But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          SCOTUS questions limit to govt efforts to fight misinformation
          SCOTUS questions limit to govt efforts to fight misinformation

          STEFANIREYNOLDS/AFPviaGettyImagesWASHINGTON— MostoftheSupremeCourt’sjusticesonMondayseemedtoquestion

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk